Prostate cancer screening british columbia.

Though prostate cancer is the most common noncutaneous cancer in males, screening practices of primary care physicians in British Columbia remain inconsistent, in part because of contradic­tory clinical guidelines.

Though prostate cancer is the most common noncutaneous cancer in males, screening practices of primary care physicians in British Columbia remain inconsistent, in part because of contradic­tory clinical guidelines.

Prostate Cancer Canada is the leading national foundation dedicated to the elimination of the most common cancer in men through research, advocacy, education, support and awareness.

Though prostate cancer is the most common noncutaneous cancer in males, screening practices of primary care physicians in British Columbia remain inconsistent, in part because of contradic­tory clinical guidelines. Aug 15, 2014 · Prostate-specific antigen (PSA) screening for prostate cancer may reduce mortality, but it incurs considerable risk of overdiagnosis and potential harm to quality of life. Our objective was to evaluate the cost-effectiveness of PSA screening, with and without adjustment for quality of life, for the British Columbia (BC) population. Aug 15, 2014 · Prostate-specific antigen (PSA) screening for prostate cancer may reduce mortality, but it incurs considerable risk of overdiagnosis and potential harm to quality of life. Our objective was to evaluate the cost-effectiveness of PSA screening, with and without adjustment for quality of life, for the British Columbia (BC) population. Prostate Cancer Canada is the leading national foundation dedicated to the elimination of the most common cancer in men through research, advocacy, education, support and awareness.